FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200213247> ?p ?o ?g. }

• W4200213247 abstract "Abstract Aims A possible interference between ACE-i or ARBs with ACE-2 receptor and SARS-CoV-2 pathway has been raised. Despite data have shown no clinical impact of therapy with ACE-I or ARBs on COVID-19, these drugs are often discontinued upon hospitalization or diagnosis. To evaluate the effects of cardiovascular risk factors (CVRF) and prior outpatient therapy with RAAS inhibitors on the chest CT severity score performed within 24 h of diagnosis of SARS-CoV-2 infection (before stopping medications or starting specific therapy for COVID-19) and on 1-year survival. Methods and results This is a multicentre, prospective, observational study. All admitted patients diagnosed with SARS-CoV-2 infection who performed chest CT within 24 h of arrival were consecutively enrolled from 1 March to 1 June 2020. A severity score was attributed to Chest CT by two radiologists in blind to the patient’s clinical information and a cut-off value of 19.5 was considered to define severe radiological pneumonia. A 1-year telephone follow-up was performed in order to evaluate the determinants of 1-year survival. 590 patients with a mean age of 63 ± 14 years were included. Seventy-three (12.4%) patients were treated with ACE-I, 85 (14.4%) with ARBs and 62 (10.5%) with CCB. Cox regression analysis showed that male gender (OR: 1.4; 95% CI: from 1.02 to 2.07; P = 0.035), diabetes (OR: 1.6; 95% CI: from 1.03 to 2.7; P = 0.037), age (OR: 1.02; 95% CI: from 1.008 to 1.033; P = 0.001), and obesity (OR: 3.04; 95% CI: from 1.3 to 6.7; P &lt; 0.001) were independently associated with a severe CT score. Of note, while prior outpatient therapy with ACE-I and ARBs was not independently associated with severe CT score, therapy with CCB was independently associated with a severe CT score (OR: 1.9, 95% CI: from 1.05 to 3.4, P = 0.033). Severe chest CT severity score (OR: 1.05; 95% CI: from 1.02 to 1.08; P &lt; 0.001), P/F ratio (OR: 0.998; 95% CI: from 0.994 to 0.998; P &lt; 0.001), and older age (OR: 1.06; 95% CI: from 1.03 to 1.1; P &lt; 0.001) were independently associated with mortality at 1-year follow-up. Neither ACE-I, ARBs, and CCB were associated with mortality at 1 year follow-up. Conclusions ACE-I and ARBs do not influence the chest CT presentation of COVID-19 patients at the time of diagnosis. Furthermore, ACE-I and ARBs do not influence 1-year survival of COVID-19 survivors." @default.
• W4200213247 created "2021-12-31" @default.
• W4200213247 creator A5002231322 @default.
• W4200213247 creator A5004595193 @default.
• W4200213247 creator A5009952922 @default.
• W4200213247 creator A5020595169 @default.
• W4200213247 creator A5021454922 @default.
• W4200213247 creator A5030176430 @default.
• W4200213247 creator A5033242180 @default.
• W4200213247 creator A5034767396 @default.
• W4200213247 creator A5036772495 @default.
• W4200213247 creator A5041821046 @default.
• W4200213247 creator A5045653993 @default.
• W4200213247 creator A5047115364 @default.
• W4200213247 creator A5048014508 @default.
• W4200213247 creator A5055478790 @default.
• W4200213247 creator A5055684454 @default.
• W4200213247 creator A5065764754 @default.
• W4200213247 creator A5066958781 @default.
• W4200213247 creator A5069899251 @default.
• W4200213247 creator A5072499317 @default.
• W4200213247 creator A5075637533 @default.
• W4200213247 creator A5078307107 @default.
• W4200213247 creator A5078647538 @default.
• W4200213247 date "2021-12-01" @default.
• W4200213247 modified "2023-09-27" @default.
• W4200213247 title "590 ACE-I and ARBS do not influence the chest CT presentation and 1-year survival of COVID-19 patients: Italian multicentre registry" @default.
• W4200213247 doi "https://doi.org/10.1093/eurheartj/suab135.007" @default.
• W4200213247 hasPublicationYear "2021" @default.
• W4200213247 type Work @default.
• W4200213247 citedByCount "0" @default.
• W4200213247 crossrefType "journal-article" @default.
• W4200213247 hasAuthorship W4200213247A5002231322 @default.
• W4200213247 hasAuthorship W4200213247A5004595193 @default.
• W4200213247 hasAuthorship W4200213247A5009952922 @default.
• W4200213247 hasAuthorship W4200213247A5020595169 @default.
• W4200213247 hasAuthorship W4200213247A5021454922 @default.
• W4200213247 hasAuthorship W4200213247A5030176430 @default.
• W4200213247 hasAuthorship W4200213247A5033242180 @default.
• W4200213247 hasAuthorship W4200213247A5034767396 @default.
• W4200213247 hasAuthorship W4200213247A5036772495 @default.
• W4200213247 hasAuthorship W4200213247A5041821046 @default.
• W4200213247 hasAuthorship W4200213247A5045653993 @default.
• W4200213247 hasAuthorship W4200213247A5047115364 @default.
• W4200213247 hasAuthorship W4200213247A5048014508 @default.
• W4200213247 hasAuthorship W4200213247A5055478790 @default.
• W4200213247 hasAuthorship W4200213247A5055684454 @default.
• W4200213247 hasAuthorship W4200213247A5065764754 @default.
• W4200213247 hasAuthorship W4200213247A5066958781 @default.
• W4200213247 hasAuthorship W4200213247A5069899251 @default.
• W4200213247 hasAuthorship W4200213247A5072499317 @default.
• W4200213247 hasAuthorship W4200213247A5075637533 @default.
• W4200213247 hasAuthorship W4200213247A5078307107 @default.
• W4200213247 hasAuthorship W4200213247A5078647538 @default.
• W4200213247 hasBestOaLocation W42002132471 @default.
• W4200213247 hasConcept C126322002 @default.
• W4200213247 hasConcept C134018914 @default.
• W4200213247 hasConcept C188816634 @default.
• W4200213247 hasConcept C23131810 @default.
• W4200213247 hasConcept C2777914695 @default.
• W4200213247 hasConcept C2779134260 @default.
• W4200213247 hasConcept C3008058167 @default.
• W4200213247 hasConcept C50382708 @default.
• W4200213247 hasConcept C524204448 @default.
• W4200213247 hasConcept C555293320 @default.
• W4200213247 hasConcept C71924100 @default.
• W4200213247 hasConceptScore W4200213247C126322002 @default.
• W4200213247 hasConceptScore W4200213247C134018914 @default.
• W4200213247 hasConceptScore W4200213247C188816634 @default.
• W4200213247 hasConceptScore W4200213247C23131810 @default.
• W4200213247 hasConceptScore W4200213247C2777914695 @default.
• W4200213247 hasConceptScore W4200213247C2779134260 @default.
• W4200213247 hasConceptScore W4200213247C3008058167 @default.
• W4200213247 hasConceptScore W4200213247C50382708 @default.
• W4200213247 hasConceptScore W4200213247C524204448 @default.
• W4200213247 hasConceptScore W4200213247C555293320 @default.
• W4200213247 hasConceptScore W4200213247C71924100 @default.
• W4200213247 hasIssue "Supplement_G" @default.
• W4200213247 hasLocation W42002132471 @default.
• W4200213247 hasLocation W42002132472 @default.
• W4200213247 hasOpenAccess W4200213247 @default.
• W4200213247 hasPrimaryLocation W42002132471 @default.
• W4200213247 hasRelatedWork W1563850031 @default.
• W4200213247 hasRelatedWork W1983368804 @default.
• W4200213247 hasRelatedWork W2032287785 @default.
• W4200213247 hasRelatedWork W2094113608 @default.
• W4200213247 hasRelatedWork W2233866314 @default.
• W4200213247 hasRelatedWork W2313076522 @default.
• W4200213247 hasRelatedWork W2383009242 @default.
• W4200213247 hasRelatedWork W2415759662 @default.
• W4200213247 hasRelatedWork W3036934084 @default.
• W4200213247 hasRelatedWork W3162081874 @default.
• W4200213247 hasVolume "23" @default.
• W4200213247 isParatext "false" @default.
• W4200213247 isRetracted "false" @default.
• W4200213247 workType "article" @default.